Research Article

Evaluation of Loop-Mediated Isothermal Amplification Assay for the Detection of Pneumocystis jirovecii in Immunocompromised Patients

Table 1

Distributions of clinical samples among different patients groups.

Underlying conditions Number of patients
()
Number of samples
()
BALFIS

HIV 642935
PRT 66624
Malignant disorders20164
Other immunocompromised states35287
Total 18513550

Other immunocompromised conditions: chronic kidney diseases (), pulmonary alveolar proteinosis (), bone marrow transplant recipient (), systemic lupus erythematosus (), post-liver transplant (), Wegner’s granulomatosis (), chronic liver disease (), and autoimmune related cirrhosis ().